{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:14:18Z","timestamp":1775758458914,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.autrev.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T08:55:12Z","timestamp":1413276912000},"page":"140-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients"],"prefix":"10.1016","volume":"14","author":[{"given":"I.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.autrev.2014.10.009_bb0445","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","article-title":"Classification of systemic sclerosis. Visions and reality","volume":"44","author":"Wollheim","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0450","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.autrev.2011.02.005","article-title":"Systemic sclerosis. Introduction","volume":"10","author":"Chighizola","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2014.10.009_bb0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12016-008-8106-x","article-title":"Vascular disease in scleroderma","volume":"36","author":"Wigley","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2014.10.009_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","article-title":"The pathogenesis, diagnosis and treatment of Raynaud phenomenon","volume":"8","author":"Herrick","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.59.1.39","article-title":"Macrovascular disease and systemic sclerosis","volume":"59","author":"Ho","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11926-012-0303-1","article-title":"Management of Raynaud's phenomenon and digital ischemia","volume":"15","author":"Herrick","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0455","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0045","doi-asserted-by":"crossref","first-page":"e92508","DOI":"10.1371\/journal.pone.0092508","article-title":"The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement","volume":"9","author":"Hutton","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2014.10.009_bb0055","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2008.09004.x","article-title":"Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors","volume":"160","author":"Sunderkotter","year":"2009","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0065","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.081044","article-title":"Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinerAIR-Sclerodermie)","volume":"36","author":"Tiev","year":"2009","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-009-1155-6","article-title":"A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost","volume":"28","author":"Caramaschi","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"Suppl. 3:iii","key":"10.1016\/j.autrev.2014.10.009_bb0460","first-page":"19","article-title":"Digital ulcers: overt vascular disease in systemic sclerosis","volume":"48","author":"Steen","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3899\/jrheum.100956","article-title":"Late-age onset systemic sclerosis","volume":"38","author":"Manno","year":"2011","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","article-title":"Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry","volume":"71","author":"Denton","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.semarthrit.2011.10.004","article-title":"Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status","volume":"41","author":"Simeon-Aznar","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3899\/jrheum.121212","article-title":"Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations","volume":"40","author":"Bacher","year":"2013","journal-title":"J Rheumatol"},{"issue":"2 Suppl. 76","key":"10.1016\/j.autrev.2014.10.009_bb0105","first-page":"46","article-title":"Clinical characteristics of systemic sclerosis patients with digital ulcers in China","volume":"31","author":"Xu","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/03009742.2013.780095","article-title":"A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact","volume":"42","author":"Ennis","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.10.009_bb0115","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-013-2668-5","article-title":"Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients","volume":"33","author":"Poormoghim","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2014.10.009_bb0465","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0130","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2622","article-title":"Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0470","first-page":"314","article-title":"Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil","volume":"51","author":"Muller Cde","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/37.1.39","article-title":"Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis","volume":"37","author":"Jacobsen","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0150","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/rheum.111133","article-title":"Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis","volume":"39","author":"Hudson","year":"2012","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.10.009_bb0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0165","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.101262","article-title":"Expert agreement on EULAR\/EUSTAR recommendations for the management of systemic sclerosis","volume":"38","author":"Walker","year":"2011","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2014.10.009_bb0175","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.110071","article-title":"Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis","volume":"38","author":"Sharif","year":"2011","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0185","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.10.009_bb0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"Clin Investig"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0195","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/ar2646","article-title":"The changing landscape of the clinical value of the PM\/Scl autoantibody system","volume":"11","author":"Mahler","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0205","first-page":"141","article-title":"Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis","volume":"158","author":"Marie","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.10.009_bb0475","article-title":"The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis","author":"Morrisroe","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2014.10.009_bb0220","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","article-title":"Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature","volume":"12","author":"Giuggioli","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","article-title":"Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases","volume":"158","author":"Spencer-Green","year":"1998","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.autrev.2014.10.009_bb0480","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/rheumatology\/ket153","article-title":"State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?","volume":"52","author":"Cutolo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2014.10.009_bb0235","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.11.006","article-title":"The role of nail-videocapillaroscopy in early diagnosis of scleroderma","volume":"12","author":"Rossi","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2014.10.009_bb0485","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","article-title":"Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity","volume":"46","author":"Caramaschi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2014.10.009_bb0245","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","article-title":"Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study","volume":"71","author":"Smith","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"66","key":"10.1016\/j.autrev.2014.10.009_bb0250","first-page":"413","article-title":"Capillaroscopic findings in systemic sclerosis \u2014 are they associated with disease duration and presence of digital ulcers?","volume":"12","author":"Lambova","year":"2011","journal-title":"Discov Med"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0255","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.2007.079756","article-title":"Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients","volume":"67","author":"Sulli","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0260","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaad.2008.11.025","article-title":"Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing","volume":"60","author":"Alivernini","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/ard.2010.132431","article-title":"Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions","volume":"70","author":"Smith","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2014.10.009_bb0270","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3899\/jrheum.130528","article-title":"Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis","volume":"40","author":"Smith","year":"2013","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.009_bb0275","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.24394","article-title":"Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients","volume":"61","author":"Sebastiani","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/annrheumdis-2011-200022","article-title":"Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study","volume":"71","author":"Sebastiani","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl. 76","key":"10.1016\/j.autrev.2014.10.009_bb0285","first-page":"115","article-title":"Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change","volume":"31","author":"Sebastiani","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.10.009_bb0490","article-title":"Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters","author":"Manfredi","year":"2014","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10067-009-1288-7","article-title":"Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0495","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/rheumatology\/ket386","article-title":"Further confirmation that digital ulcers are associated with the severity of abnormality on nailfold capillaroscopy in patients with systemic sclerosis","volume":"53","author":"Ennis","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"S3","key":"10.1016\/j.autrev.2014.10.009_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/annrheumdis-2013-eular.480","article-title":"Nailfold videocapillaroscopy and other predictive factors associated with new digital ulcers in systemic sclerosis. Data from the CAP study","volume":"72","author":"Cutolo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.10.009_bb0310","doi-asserted-by":"crossref","first-page":"125632","DOI":"10.1155\/2013\/125632","article-title":"Endothelin-1 levels in scleroderma patients: a pilot study","volume":"2013","author":"Cozzani","year":"2013","journal-title":"ISRN Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/2229-5178.93484","article-title":"Endothelin-1 in systemic sclerosis","volume":"3","author":"Aghaei","year":"2012","journal-title":"Ind Dermatol Online J"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0320","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3899\/jrheum.081030","article-title":"Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis","volume":"36","author":"Sulli","year":"2009","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0500","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0505","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/rheumatology\/kei276","article-title":"Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine","volume":"45","author":"Dooley","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2014.10.009_bb0510","first-page":"1483","article-title":"Predictors of digital ulcers in systemic sclerosis: correlation between clinical and hemodynamic features, capillaroscopy, endothelium dysfunction and angiogenesis biomarkers","volume":"64","author":"Silva","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2014.10.009_bb0515","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kes068","article-title":"Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0520","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","article-title":"von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?","volume":"34","author":"Lip","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0350","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar295","article-title":"Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)","volume":"3","author":"Scheja","year":"2001","journal-title":"Arthritis Res"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0355","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.autrev.2014.10.009_bb0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.autrev.2014.10.009_bb0525","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/rheumatology\/kep154","article-title":"The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis","volume":"48","author":"Solanilla","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2478\/v10039-011-0025-z","article-title":"Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease","volume":"56","author":"Bielecki","year":"2011","journal-title":"Adv Med Sci"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0375","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1756-185X.12130","article-title":"Dysregulation of angiogenic homeostasis in systemic sclerosis","volume":"16","author":"Farouk","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends cardiovasc Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0385","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0395","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","article-title":"Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis","volume":"43","author":"Hebbar","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.10.009_bb0400","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","article-title":"Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis","volume":"71","author":"Avouac","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0530","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/keq392","article-title":"Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease","volume":"50","author":"Michalska-Jakubus","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.10.009_bb0535","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2340\/00015555-1680","article-title":"Serum angiopoietin-like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosis","volume":"94","author":"Ichimura","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.autrev.2014.10.009_bb0415","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.10.009_bb0420","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2014.10.009_bb0425","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.10.009_bb0540","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2013.12.002","article-title":"Socioeconomic status. The relationship with health and autoimmune diseases","volume":"13","author":"Calixto","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.009_bb0435","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3899\/jrheum.120570","article-title":"Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group","volume":"40","author":"Mansour","year":"2013","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.10.009_bb0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:52:10Z","timestamp":1538146330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1568997214002213"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}